✦ LIBER ✦

Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation

✍ Scribed by Takafumi Ichida; Yutaka Narita; Romi Murakami

Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 102 KB
Volume: 41
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-006-1959-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card

✍ Richard B. Freeman Jr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Impact of model for end-stage liver dise

Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation

✍ Urmila Khettry; Gissou Azabdaftari; Mary Ann Simpson; Elizabeth A. Pomfret; Jame 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

The Model for End-Stage Liver Disease (MELD) scoring system, a validated objective liver disease severity scale, was adopted in February 2002 to allocate cadaveric organs for liver transplantation (LT). To improve transplantability before succumbing to advanced disease, patients with low-stage hepat

The model for end-stage liver disease (M

The model for end-stage liver disease (MELD)

✍ Patrick S. Kamath; W. Ray Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for polycystic liver disease

✍ Luis Arrazola; Dilip Moonka; Robert G. Gish; Gregory T. Everson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception guidelines

✍ Russell Wiesner; John R. Lake; Richard B. Freeman; Robert G. Gish 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

The model for end-stage liver disease sc

The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation

✍ Takayuki Kogure; Yoshiyuki Ueno; Naoki Kawagishi; Noriatsu Kanno; Yoko Yamagiwa; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 175 KB